Blindness, Acquired: Clinical Trials

8 trials for Blindness, Acquired, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 enrolling by invitation. 7 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable7Unknown 2, Active not recruiting 1, Completed 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1

Follow Blindness, Acquired: new trials by email Literature Review of Blindness, Acquired trials Research Report on Blindness, Acquired

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
Integrated Cognitive Behavioral Therapy (CBT) & Mindfulness Group Intervention for Adjustment to Vision Loss - Depression, Anxiety, Visual Impairment
Not applicableRecruitingThe Chicago Lighthouse452025-07-142025-07-30
AI-Powered Artificial Vision for Visual Prostheses
Visual prosthesis - Blindness, Acquired
Not applicableEnrolling by invitationUniversity of California, Santa Barbara72023-10-022026-08-20
Advanced Spatiomotor Rehabilitation for Navigation in Blindness & Visual Impairment
Cognitive-Kinesthetic Navigational Training - Blindness, Blindness, Acquired
Not applicableUnknownSmith-Kettlewell Eye Research Institute752022-02-152023-11-22
A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
Blindness, Acquired
SuspendedSecond Sight Medical Products32020-03-062023-11-22
Effects of Transcranial Direct Current Stimulation With Proprioceptive Training in Blind People
active tDCS, sham tDCS, Dynamic proprioceptive exercises - Blindness, Acquired, Blindness Congenital
Not applicableUnknownSalgado Institute of Integral Health402019-09-302020-10-30
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
Orion Visual Cortical Prosthesis System - Blindness, Acquired
Not applicableActive not recruitingSecond Sight Medical Products62017-11-202025-01-27
Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
EyeMate - Glaucoma, Blindness, Acquired
Not applicableWithdrawnCentre hospitalier de l'Université de Montréal (CHUM)2016-11-012018-02-05
Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.
Laminar drainage implant surgery. - Glaucoma, Blindness, Acquired
Not applicableCompletedFederal University of Minas Gerais152011-03-012017-05-25

Narrower conditions

Blindness (8)  ·  Glaucoma (2)  ·  Vision, Low (2)  ·  Anxiety Disorders (1)  ·  Corneal Diseases (1)  ·  Corneal Injuries (1)  ·  Corneal Opacity (1)  ·  Depression (1)  ·  Keratitis, Herpetic (1)  ·  Pemphigoid, Benign Mucous Membrane (1)  ·  Psychological Well-Being (1)  ·  Vision Disorders (1)

Broader conditions

Eye Diseases (8)  ·  Nervous System Diseases (8)  ·  Neurologic Manifestations (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Sensation Disorders (8)  ·  Signs and Symptoms (8)  ·  Vision Disorders (7)  ·  Ocular Hypertension (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Conjunctival Diseases (1)  ·  Craniocerebral Trauma (1)  ·  DNA Virus Infections (1)  ·  Eye Infections (1)  ·  Eye Infections, Viral (1)

Interventions

Transcranial Direct Current Stimulation (1)  ·  Visual Prosthesis (1)

Sponsors

Second Sight Medical Products (2)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  Federal University of Minas Gerais (1)  ·  Salgado Institute of Integral Health (1)  ·  Smith-Kettlewell Eye Research Institute (1)  ·  The Chicago Lighthouse (1)  ·  University of California, Santa Barbara (1)

Countries

United States (5)  ·  Brazil (1)  ·  Spain (1)

Top investigators

Uday Patel, PhD (2)  ·  Lora T Likova (1)  ·  Michael Beyeler, PhD (1)  ·  Mona Harissi-Dagher, MD (1)  ·  Rodolfo B Parreira, MSc (1)

Results publications

PMID 10990547, PMID 12807923, PMID 16467613, PMID 16926202, PMID 16982502, PMID 17611240, PMID 19701648, PMID 20853264, PMID 21620985, PMID 21632004, PMID 22593738, PMID 23346061, PMID 23778351, PMID 23873397, PMID 25361555, PMID 28104418, PMID 28347878, PMID 28442686, PMID 28890944, PMID 31633079, PMID 32413298, PMID 33223582, PMID 34566588

NIH funding

5UH3NS103442 (1)